Ketone monoester (KME) ingestion lowers cerebral blood flow (CBF), likely due to reduced arterial carbon dioxide (P
a
CO
2
). We tested the hypothesis that maintaining end-tidal CO
2
(P
ET
CO
2
; surrogate for P
a
CO
2
) following KME ingestion would prevent reductions in CBF and improve cerebrovascular reactivity (CVR) to CO
2
compared to free-breathing. In a single-blinded randomized crossover design, twenty-three adults (age=22±2 yrs) ingested 0.6 g·kg
-1
KME and breathed either room air (poikilocapnia) or a gas mixture that clamped P
ET
CO
2
at baseline (isocapnia) for 60 min. CVR to CO
2
was assessed at targeted P
ET
CO
2
of +3, +6, and +9 mmHg above baseline. CBF was assessed using duplex ultrasound of extracranial arteries and transcranial Doppler ultrasound of the middle cerebral artery. Venous β-hydroxybutyrate, pH, and bicarbonate were measured. Outcomes were assessed at baseline, 45-, and 60-min post-supplementation. P
ET
CO
2
was higher during isocapnia at 45 min (3.9±3.8 mmHg; P<0.001) and 60 min (4.4±3.8 mmHg; P<0.001) post-supplementation corresponding with 15% higher CBF compared to poikilocapnia ( P<0.001). Blood pH was reduced during isocapnia ( P<0.001), whereas it was unchanged in poikilocapnia ( P=0.246), suggesting that the ventilatory response to KME ingestion effectively buffered metabolic acidosis in poikilocapnia. CVR to CO
2
was reduced following KME ingestion regardless of condition ( P<0.001). Exploratory analyses demonstrated that biological sex did not alter cerebrovascular responses to KME ingestion. This work confirms that reductions in CBF and CVR to CO
2
following KME ingestion are due to reduced P
a
CO
2
in response to metabolic acidosis. Strategies that buffer metabolic acidosis likely will mitigate CBF reductions following acute KME ingestion.